ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
reon1
|
14K |
6.6M |
6 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
14K
|
6.6M
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
reon1
|
14K |
6.6M |
7 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
14K
|
6.6M
|
7
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial
|
|
reon1
|
1 |
630 |
4 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
1
|
630
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Pipeline-in-a-drug
|
|
reon1
|
61 |
11K |
11 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
61
|
11K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Pipeline-in-a-drug
|
|
reon1
|
61 |
11K |
6 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
61
|
11K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Pipeline-in-a-drug
|
|
reon1
|
61 |
11K |
8 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
61
|
11K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
reon1
|
539 |
125K |
5 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
539
|
125K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Pipeline-in-a-drug
|
|
reon1
|
61 |
11K |
21 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
61
|
11K
|
21
|
|
ASX - By Stock
|
AS2 |
Re:
Ann: Askari Accelerate Exploration at Seven New Pegmatite Targets
|
|
reon1
|
8 |
1.6K |
0 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
8
|
1.6K
|
0
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
reon1
|
539 |
125K |
6 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
539
|
125K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
reon1
|
703 |
284K |
4 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
703
|
284K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
reon1
|
703 |
284K |
3 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
703
|
284K
|
3
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study
|
|
reon1
|
168 |
32K |
4 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
168
|
32K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
reon1
|
14K |
6.6M |
5 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
14K
|
6.6M
|
5
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust reappoints MD and resets its sights on MND battle
|
|
reon1
|
15 |
4.6K |
4 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
15
|
4.6K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust reappoints MD and resets its sights on MND battle
|
|
reon1
|
15 |
4.6K |
3 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
15
|
4.6K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Presentation to Bell Potter Conference
|
|
reon1
|
159 |
72K |
21 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
159
|
72K
|
21
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Presentation to Bell Potter Conference
|
|
reon1
|
159 |
72K |
45 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
159
|
72K
|
45
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Presentation to Bell Potter Conference
|
|
reon1
|
159 |
72K |
12 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
159
|
72K
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Presentation to Bell Potter Conference
|
|
reon1
|
159 |
72K |
31 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
159
|
72K
|
31
|
|
ASX - By Stock
|
WR1 |
Re:
WR1 General Discussion
|
|
reon1
|
30K |
6.9M |
2 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
30K
|
6.9M
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Presentation to Bell Potter Conference
|
|
reon1
|
159 |
72K |
31 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
159
|
72K
|
31
|
|
ASX - By Stock
|
WBT |
Re:
Question re revenue potential
|
|
reon1
|
144 |
66K |
2 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
144
|
66K
|
2
|
|
ASX - By Stock
|
EVR |
Bailing out of BMM
|
|
reon1
|
10 |
2.4K |
2 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
10
|
2.4K
|
2
|
|
ASX - By Stock
|
WBT |
Re:
Question re revenue potential
|
|
reon1
|
144 |
66K |
7 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
144
|
66K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
reon1
|
24K |
11M |
4 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
24K
|
11M
|
4
|
|
ASX - By Stock
|
SKO |
Re:
Ann: Serko's Audited FY24 Financial Results
|
|
reon1
|
3 |
815 |
0 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
3
|
815
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
reon1
|
24K |
11M |
56 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
24K
|
11M
|
56
|
|
ASX - By Stock
|
SNT |
Re:
Syntara the science explained
|
|
reon1
|
42 |
9.9K |
6 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
42
|
9.9K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ph I/II UTI/Urosepsis Trial Dosing Commenced in Next Cohort
|
|
reon1
|
7 |
2.4K |
6 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
7
|
2.4K
|
6
|
|
ASX - By Stock
|
AS2 |
Re:
Ann: High-Grade Mineralisation and Visible Spodumene at Kestrel
|
|
reon1
|
21 |
5.1K |
1 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
21
|
5.1K
|
1
|
|
ASX - By Stock
|
LLI |
Re:
Ann: Loyal Lithium Raises $3.3M at 73% Premium to Market
|
|
reon1
|
31 |
7.2K |
9 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
31
|
7.2K
|
9
|
|
ASX - By Stock
|
LLI |
Re:
Ann: Loyal Lithium Raises $3.3M at 73% Premium to Market
|
|
reon1
|
31 |
7.2K |
9 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
31
|
7.2K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
From the Professor...
|
|
reon1
|
178 |
81K |
20 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
178
|
81K
|
20
|
|
ASX - By Stock
|
LLI |
Re:
Ann: Loyal Lithium Raises $3.3M at 73% Premium to Market
|
|
reon1
|
31 |
7.2K |
19 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
31
|
7.2K
|
19
|
|
ASX - By Stock
|
IMU |
Re:
From the Professor...
|
|
reon1
|
178 |
81K |
14 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
178
|
81K
|
14
|
|
ASX - By Stock
|
IMU |
Re:
From the Professor...
|
|
reon1
|
178 |
81K |
54 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
178
|
81K
|
54
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study
|
|
reon1
|
168 |
32K |
2 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
168
|
32K
|
2
|
|
ASX - By Stock
|
LLI |
Re:
Ann: Trading Halt
|
|
reon1
|
13 |
4.1K |
3 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
13
|
4.1K
|
3
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study
|
|
reon1
|
168 |
32K |
1 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
168
|
32K
|
1
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study
|
|
reon1
|
168 |
32K |
2 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
168
|
32K
|
2
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study
|
|
reon1
|
168 |
32K |
3 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
168
|
32K
|
3
|
|
ASX - By Stock
|
PR1 |
Re:
Ann: Sale of Swedish Project for Cash & Reduced Lithium Exposure
|
|
reon1
|
4 |
1.0K |
1 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
4
|
1.0K
|
1
|
|
ASX - By Stock
|
LLI |
Re:
Ann: Trading Halt
|
|
reon1
|
13 |
4.1K |
6 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
13
|
4.1K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
reon1
|
14K |
6.6M |
5 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
14K
|
6.6M
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
reon1
|
104 |
30K |
1 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
104
|
30K
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Running discussion on SP
|
|
reon1
|
8.1K |
3.2M |
3 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
8.1K
|
3.2M
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
reon1
|
250 |
63K |
3 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
250
|
63K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
reon1
|
405 |
63K |
14 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
405
|
63K
|
14
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
reon1
|
405 |
63K |
8 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
405
|
63K
|
8
|
|